BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27092539)

  • 1. Breath-Powered Intranasal Sumatriptan Dry Powder.
    Tepper D
    Headache; 2016 Apr; 56(4):817-8. PubMed ID: 27092539
    [No Abstract]   [Full Text] [Related]  

  • 2. Onzetra Xsail--sumatriptan nasal powder.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
    Tepper SJ
    Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
    Silberstein SD
    Expert Opin Drug Saf; 2018 Jan; 17(1):89-97. PubMed ID: 28994319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Question 2: Does intranasal sumatriptan use relieve migraine in children and young people?
    Yong JW; Anand G
    Arch Dis Child; 2013 Jan; 98(1):82-4. PubMed ID: 23255042
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal sumatriptan for migraine in children.
    Goldman RD; Meckler GD
    Can Fam Physician; 2015 May; 61(5):435-7. PubMed ID: 25971759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.
    Silberstein S
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):821-832. PubMed ID: 28605258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan iontophoretic patch for migraine.
    Tepper DE
    Headache; 2014 Oct; 54(9):1563-4. PubMed ID: 25324166
    [No Abstract]   [Full Text] [Related]  

  • 9. A sumatriptan patch (Zecuity) for migraine.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder.
    Obaidi M; Offman E; Messina J; Carothers J; Djupesland PG; Mahmoud RA
    Headache; 2013 Sep; 53(8):1323-33. PubMed ID: 23992438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel intranasal breath-powered delivery system for sumatriptan: a review of technology and clinical application of the investigational product AVP-825 in the treatment of migraine.
    Cady R
    Expert Opin Drug Deliv; 2015; 12(9):1565-77. PubMed ID: 26119828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of sumatriptan intranasal powder in adults with acute migraine.
    Freitag FG; Shumate DA
    Expert Rev Neurother; 2016 Jul; 16(7):743-7. PubMed ID: 27260875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan Nasal Powder: A Review in Acute Treatment of Migraine.
    Al-Salama ZT; Scott LJ
    Drugs; 2016 Oct; 76(15):1477-1484. PubMed ID: 27681528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary.
    Rothrock JF
    Headache; 2011 Apr; 51(4):518-9. PubMed ID: 21457236
    [No Abstract]   [Full Text] [Related]  

  • 16. Could inhaled drug formulations be the future of acute migraine treatment?
    Abdou EM
    Ther Deliv; 2019 Oct; 10(10):609-611. PubMed ID: 31646944
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study.
    Djupesland PG; Docekal P;
    Cephalalgia; 2010 Aug; 30(8):933-42. PubMed ID: 20656704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Vikelis M; Mitsikostas DD; Rapoport AM
    Pain Manag; 2014 Mar; 4(2):123-8. PubMed ID: 24641436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches.
    Freitag FG
    Expert Rev Neurother; 2011 Apr; 11(4):481-90. PubMed ID: 21469920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
    Pierce M; O'Neill C; Felker E; Sebree T
    Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.